rs1441937959
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1556411578
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1556463583
|
|
CA |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1559643753
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1569497030
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs199469465
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs533297350
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs569681869
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs779593707
|
|
CAATA |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs121912861
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Two stop codons (R1377X and 2788/91delG) and a glycine substitution (G960R) resulted in hematuria in all 16 members who were tested from these three families.
|
12631110 |
2003 |
rs1285576172
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Two stop codons (R1377X and 2788/91delG) and a glycine substitution (G960R) resulted in hematuria in all 16 members who were tested from these three families.
|
12631110 |
2003 |
rs769783985
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Two stop codons (R1377X and 2788/91delG) and a glycine substitution (G960R) resulted in hematuria in all 16 members who were tested from these three families.
|
12631110 |
2003 |
rs797044813
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The phenotypes of the two patients with R637X were very similar to those of Japanese patients, i.e., they presented with asymptomatic proteinuria without rickets, renal failure or hematuria.
|
15719255 |
2005 |
rs137876000
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Identification of two novel mutations C79X and R235Q in the dihydropyrimidine dehydrogenase gene in a patient presenting with hematuria.
|
18600544 |
2008 |
rs755416212
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Identification of two novel mutations C79X and R235Q in the dihydropyrimidine dehydrogenase gene in a patient presenting with hematuria.
|
18600544 |
2008 |
rs12118043
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Associations between FCGR2B rs12118043 and proteinuria (p = 3.65×10(-2)) as well as gross hematuria (p = 4.53×10(-2)), between FCRLB rs4657093 and levels of serum creatinine (p = 2.67×10(-2)) as well as eGFR (p = 5.41*10(-3)) were also observed.
|
23593433 |
2013 |
rs4657093
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Associations between FCGR2B rs12118043 and proteinuria (p = 3.65×10(-2)) as well as gross hematuria (p = 4.53×10(-2)), between FCRLB rs4657093 and levels of serum creatinine (p = 2.67×10(-2)) as well as eGFR (p = 5.41*10(-3)) were also observed.
|
23593433 |
2013 |
rs9644778
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Besides, marginally significant association of rs9644778 risk genotype with lower proportion of gross hematuria (CC+CA vs AA 35.2% vs 30.2%, P=0.073) was observed.
|
25675412 |
2016 |
rs2277798
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Moreover, we found that the genotype distribution of rs2277798 was significantly associated with hematuria in the SLE patients (p=0.003).
|
25843625 |
2015 |
rs1695
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In addition, patients with the GSTP1 rs1695 AA genotype had an increased risk of irritative voiding symptoms; while patients with the GSTO1 rs4925 CC genotype had a decreased risk of hematuria.
|
26354850 |
2015 |
rs4925
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In addition, patients with the GSTP1 rs1695 AA genotype had an increased risk of irritative voiding symptoms; while patients with the GSTO1 rs4925 CC genotype had a decreased risk of hematuria.
|
26354850 |
2015 |
rs200287952
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Sequence variants associating with urinary biomarkers.
|
30476138 |
2019 |
rs56254331
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Sequence variants associating with urinary biomarkers.
|
30476138 |
2019 |
rs760545501
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Sequence variants associating with urinary biomarkers.
|
30476138 |
2019 |
rs121909585
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Homozygous C3 p.D1115N (C3KI) mice developed spontaneous chronic thrombotic microangiopathy together with hematuria, thrombocytopenia, elevated creatinine, and evidence of hemolysis.
|
30714990 |
2019 |